Turtle Cameron

Insider·Spyre Therapeutics, Inc.·SYRE·Insider since 2025·Form 4 filings: 9
Trades YTD
5
Trades (12m)
9
Net position
Current holdings
P-code buys (12m)
0
Cluster
None

Transaction history · last 12 months

9 transactions
02 Feb 2026
SOLD
$SYRE
14,043
$32.87
S
02 Feb 2026
SOLD
$SYRE
957
$31.82
S
02 Jan 2026
SOLD
$SYRE
100
$32.39
S
02 Jan 2026
SOLD
$SYRE
2,191
$31.79
S
02 Jan 2026
SOLD
$SYRE
12,709
$30.47
S
01 Dec 2025
SOLD
$SYRE
4,005
$29.83
S
01 Dec 2025
SOLD
$SYRE
10,995
$28.73
S
03 Nov 2025
SOLD
$SYRE
16,845
$23.66
S
03 Nov 2025
SOLD
$SYRE
28,155
$23.13
S

Transaction codes: P open-market purchase · S sale · M option exercise · A grant.

Cluster context · Spyre Therapeutics, Inc.

last 30 days

No active insider cluster at Spyre Therapeutics, Inc. in the last 30 days. Cameron's recent transactions appear in the section above.

Convergence · Pattern Engine ships in v1.1

30-day window
In development

Convergence participation lands with the Pattern Engine.

Once the Pattern Engine ships, this section will list every active convergence event Cameron is named in — the hedge funds and Congress members on the same name, the 30-day window, and the combined position size.

Context

Form 4 background

Form 4 filings are required within two business days of any insider transaction by an officer, director, or 10%+ shareholder. Open-market purchases (transaction code P) are the most signal-rich because they indicate the insider is paying market price with personal cash — as distinct from option exercises, scheduled sales, or compensation grants. Cluster buying — three or more insiders of the same company buying open-market shares in a 30-day window — has historically been one of the strongest positive insider-trading signals in the academic literature.

Source data: SEC EDGAR · Form 4 filings · Last refreshed 12:17 UTC.